Inventurus Knowledge Solutions Ltd (IKS Health) has launched MyCareHub™, a new platform designed to automate and personalize patient engagement. A case study with practice OrthoNY demonstrated the platform's effectiveness, showing a 4.7% increase in total patient collections and a 9.4% rise in patient payments per visit.
Platform Launch Details
IKS Health announced MyCareHub™ on April 15, 2026, during the AMGA Annual Conference. This system is built to automate and personalize patient interactions throughout their healthcare journey. The platform, rolled out at OrthoNY in 2025, is described as an intelligence system that manages patient interactions across the entire care lifecycle.
The OrthoNY case study highlighted significant financial improvements:
- 4.7% increase in total patient collections
- 9.4% rise in patient payments per visit
- 8.25% increase in net payments per visit
Why It Matters
MyCareHub™ represents IKS Health's strategic expansion into advanced AI solutions for the healthcare sector. By automating and personalizing patient engagement, the platform aims to streamline operations for healthcare providers. This can lead to improved financial metrics, such as enhanced revenue cycle management and patient satisfaction.
Company Background
IKS Health, founded in 2006, is a healthcare technology company focused on expanding its AI capabilities. The company received a Google Cloud DORA Award in 2025 for its work augmenting human expertise with AI.
To strengthen its U.S. market presence and patient billing solutions, IKS Health is reportedly in advanced talks to acquire U.S.-based TruBridge for approximately $600 million, which would be its largest acquisition to date. This follows the October 2023 acquisition of Aquity Solutions for $200 million. In April 2026, the company also invested $21 million in its U.S. subsidiary, IKS Inc.
Key Impacts
- Healthcare organizations can use MyCareHub™ for automated, personalized patient engagement.
- The platform offers potential for improved financial performance, especially in patient collections.
- IKS Health further establishes itself as an innovator in AI-driven healthcare technology.
- Successful adoption of MyCareHub™ could encourage broader use of AI in patient management.
Potential Risks
- The OrthoNY case study includes a disclaimer, "Outcomes may vary," indicating results are not guaranteed for all clients.
- IKS Health relies heavily on the U.S. market, which generates about 96% of its revenue.
- High employee turnover remains a challenge for the company.
- IKS Health faced penalties from the RBI for delays in foreign exchange compliance, though the company stated these had no material impact.
Competitor Landscape
IKS Health operates in a competitive healthcare technology market. Key competitors include Innovaccer (healthcare intelligence platforms), Eka Care (AI-powered EMR/EHR and patient engagement), eClinicalWorks (EMR/PM solutions with patient engagement tools), and Techimply India (AI-driven patient engagement platforms).
Company Metrics
- IKS Health reported revenue of ₹2,700 crore for the fiscal year ending March 31, 2025.
- The company employed 7,633 people as of May 31, 2025.
Future Focus
- Monitor the adoption rate of MyCareHub™ by other healthcare providers.
- Look for additional performance data from MyCareHub™ implementations.
- Track developments regarding the potential TruBridge acquisition, which could significantly alter IKS Health's market position.
- Observe further announcements detailing MyCareHub™'s impact on client financials.
- Follow IKS Health's progress in expanding its U.S. operations, particularly after recent investments.